OpenArc Corporate Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
OpenArc Corporate Advisory's ELV Position: Q2 2026 in Review
OpenArc Corporate Advisory increased its Elevance Health (ELV) stake by 3.4% in Q2 2026, buying an estimated $21.5K and bringing the position to 1,747 shares worth $676K. The position accounts for 0.01% of the portfolio, ranked #410.
OpenArc Corporate Advisory first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- OpenArc Corporate Advisory held 1,747 shares of Elevance Health worth $676K as of Q2 2026.
- OpenArc Corporate Advisory bought 58 Elevance Health shares in Q2 2026, an estimated $21.5K.
- Elevance Health made up 0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #410 holding.
- OpenArc Corporate Advisory first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.